Is This Under-the-Radar Biotech Stock a Buy Near an All-Time High?
Repligen has grown product revenue 220% since 2014, but it trades at 70 times future earnings. What should investors make of that?
via FOX BUSINESS NEWS https://ift.tt/2HOE1cO
About TIAMIYU SODIQ .O.
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.
No comments:
Post a Comment